Luis Alberto Oliveira Dallan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Luis Alberto Oliveira Dallan has a total of 205 co-authors. Here are the top co-authors by number of shared publications:
- Fabio Biscegli Jatene
Universidade de São Paulo
13 shared publications - Luiz Augusto Ferreira Lisboa
Universidade de São Paulo, Brasil
11 shared publications - Omar Asdrúbal Vilca Mejia
Universidade de São Paulo, Brasil
10 shared publications Fabio B. Jatene
Division of Cardiovascular Surgery, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil
6 shared publications- Bruno Mahler Mioto
Universidade de São Paulo, Brasil
5 shared publications Luiz Augusto Ferreira Lisboa
Instituto do Coração, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Sao Paulo, Brasil
5 shared publications
Latest Publications
- Open Access
- 17 November 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (20) , 1988-2000
Off-Pump Versus On-Pump Coronary Artery Bypass Grafting in Prefrail and Frail Patients: 30-Day and 1-Year Outcomes From the FRAGILE Randomized Trial
BACKGROUND: Frailty is associated with worse outcomes after coronary artery bypass grafting (CABG). However, the comparative effectiveness of off-pump CABG (OPCAB) versus on-pump CABG (ONCAB) in prefrail and frail patients remains uncertain. METHODS: This multicenter, randomized, open-label trial enrolled patients ≥60 years of age classified as prefrail or frail, randomized 1:1, between January 2018 and December 2024. The primary outcome was a 30-day composite of death, myocardial infarction, stroke, renal failure, acute respiratory distress syndrome, or reoperation for bleeding. Secondary outcomes included ventilation time, intensive care unit and hospital stay, transfusion requirements, completeness of revascularization, surgical wound infection at 30 days, and neurocognitive function preoperatively and at 1 year. Analyses followed the intention-to-treat principle; relative risks with 95% CIs were estimated. RESULTS: A total of 508 patients were included (OPCAB, n=258; ONCAB, n=250; median age, 68 years [interquartile range, 65.0–73]; 30.5% female). The primary composite outcome occurred in 28 patients receiving OPCAB (10.9%) and 40 patients receiving ONCAB (16.0%; relative risk, 1.47 [95% CI, 0.94–2.31]; P =0.09). Surgical wound infection was more frequent with ONCAB (20 [8.0%] versus 9 [3.5%]; P =0.04). No significant differences were observed in neurocognitive or quality of life outcomes at 1 year. Estimated 1-year survival probabilities were 96.1% and 92.8% in the OPCAB and ONCAB groups, respectively ( P =0.099). CONCLUSIONS: In prefrail and frail patients undergoing CABG, OPCAB and ONCAB resulted in similar rates of the primary composite outcome. No significant differences between OPCAB and ONCAB were found in neurocognitive outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02338947.
- 17 November 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 154 (20) , 1988-2000
Open AccessOff-Pump Versus On-Pump Coronary Artery Bypass Grafting in Prefrail and Frail Patients: 30-Day and 1-Year Outcomes From the FRAGILE Randomized Trial
BACKGROUND: Frailty is associated with worse outcomes after coronary artery bypass grafting (CABG). However, the comparative effectiveness of off-pump CABG (OPCAB) versus on-pump CABG (ONCAB) in prefrail and frail patients remains uncertain. METHODS: This multicenter, randomized, open-label trial enrolled patients ≥60 years of age classified as prefrail or frail, randomized 1:1, between January 2018 and December 2024. The primary outcome was a 30-day composite of death, myocardial infarction, stroke, renal failure, acute respiratory distress syndrome, or reoperation for bleeding. Secondary outcomes included ventilation time, intensive care unit and hospital stay, transfusion requirements, completeness of revascularization, surgical wound infection at 30 days, and neurocognitive function preoperatively and at 1 year. Analyses followed the intention-to-treat principle; relative risks with 95% CIs were estimated. RESULTS: A total of 508 patients were included (OPCAB, n=258; ONCAB, n=250; median age, 68 years [interquartile range, 65.0–73]; 30.5% female). The primary composite outcome occurred in 28 patients receiving OPCAB (10.9%) and 40 patients receiving ONCAB (16.0%; relative risk, 1.47 [95% CI, 0.94–2.31]; P =0.09). Surgical wound infection was more frequent with ONCAB (20 [8.0%] versus 9 [3.5%]; P =0.04). No significant differences were observed in neurocognitive or quality of life outcomes at 1 year. Estimated 1-year survival probabilities were 96.1% and 92.8% in the OPCAB and ONCAB groups, respectively ( P =0.099). CONCLUSIONS: In prefrail and frail patients undergoing CABG, OPCAB and ONCAB resulted in similar rates of the primary composite outcome. No significant differences between OPCAB and ONCAB were found in neurocognitive outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02338947.
- Open Access
- 29 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (12) , e0337829
Minimally invasive coronary artery bypass grafting (MINI-CABG): Protocol for a pilot randomized controlled trial comparing minimally invasive versus conventional coronary surgery
Introduction: Coronary artery bypass grafting (CABG) via sternotomy remains the standard of care for multivessel coronary disease. Minimally invasive cardiac surgery for coronary artery bypass grafting (MICS-CABG) is an evolving technique with the potential to reduce surgical trauma and promote faster recovery without compromising outcomes. This protocol describes a pilot randomized controlled trial comparing MICS-CABG and conventional CABG in multivessel patients in a high-volume tertiary center. Methods and analysis: This is a single-center, prospective, randomized controlled pilot trial. A total of 100 patients with multivessel coronary artery disease will be randomized (1:1) to undergo either conventional CABG via median sternotomy or MICS-CABG through a left anterior thoracotomy. The sample size of 100 patients (50 per group) was defined based on feasibility and statistical precision. This allows estimation of an expected 8% major adverse cardiovascular and cerebrovascular events (MACCE) rate with a 95% confidence interval half-width of ±5% in each group. These data will inform sample size calculations for a future phase III trial. The primary outcomes are safety and feasibility. Feasibility will be assessed by the successful completion of the planned minimally invasive coronary revascularization strategy. Safety will be evaluated through the occurrence of MACCE within 30 days postoperatively. Secondary outcomes include operative time, mechanical ventilation time, conversion rate to sternotomy, bleeding volume, atrial fibrillation, postoperative ICU and hospital length of stay, and patient-reported quality of life (EQ-5D-5L) 6 months postoperatively. The trial is ongoing at this moment. Ethics and dissemination: The protocol was approved by the Institutional Research Ethics Committee under que number CAAE: 54175921.8.0000.0068. Results will be disseminated through peer-reviewed publications and scientific conferences. Trial registration number: ClinicalTrials.gov NCT06794359 .
- 29 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (12) , e0337829
Open AccessMinimally invasive coronary artery bypass grafting (MINI-CABG): Protocol for a pilot randomized controlled trial comparing minimally invasive versus conventional coronary surgery
Introduction: Coronary artery bypass grafting (CABG) via sternotomy remains the standard of care for multivessel coronary disease. Minimally invasive cardiac surgery for coronary artery bypass grafting (MICS-CABG) is an evolving technique with the potential to reduce surgical trauma and promote faster recovery without compromising outcomes. This protocol describes a pilot randomized controlled trial comparing MICS-CABG and conventional CABG in multivessel patients in a high-volume tertiary center. Methods and analysis: This is a single-center, prospective, randomized controlled pilot trial. A total of 100 patients with multivessel coronary artery disease will be randomized (1:1) to undergo either conventional CABG via median sternotomy or MICS-CABG through a left anterior thoracotomy. The sample size of 100 patients (50 per group) was defined based on feasibility and statistical precision. This allows estimation of an expected 8% major adverse cardiovascular and cerebrovascular events (MACCE) rate with a 95% confidence interval half-width of ±5% in each group. These data will inform sample size calculations for a future phase III trial. The primary outcomes are safety and feasibility. Feasibility will be assessed by the successful completion of the planned minimally invasive coronary revascularization strategy. Safety will be evaluated through the occurrence of MACCE within 30 days postoperatively. Secondary outcomes include operative time, mechanical ventilation time, conversion rate to sternotomy, bleeding volume, atrial fibrillation, postoperative ICU and hospital length of stay, and patient-reported quality of life (EQ-5D-5L) 6 months postoperatively. The trial is ongoing at this moment. Ethics and dissemination: The protocol was approved by the Institutional Research Ethics Committee under que number CAAE: 54175921.8.0000.0068. Results will be disseminated through peer-reviewed publications and scientific conferences. Trial registration number: ClinicalTrials.gov NCT06794359 .
- Open Access
- 14 October 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
Guideline for Chronic Coronary Syndrome – 2025
- 14 October 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
Open AccessGuideline for Chronic Coronary Syndrome – 2025
- 16 September 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (09) , e20250619
Diretriz de Síndrome Coronariana Crônica – 2025
- 16 September 2025
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 122 (09) , e20250619
Diretriz de Síndrome Coronariana Crônica – 2025
- Open Access
- 1 January 2025
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 40 (4) , e20230332
Is the Fate of the Internal Mammary Vein in CABG Similar to that of the Saphenous Vein?
- 1 January 2025
- Published by Sociedade Brasileira de Cirurgia Cardiovascular in Brazilian Journal of Cardiovascular Surgery
- Vol. 40 (4) , e20230332
Open AccessIs the Fate of the Internal Mammary Vein in CABG Similar to that of the Saphenous Vein?
- Open Access
- 1 March 2023
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 120 (3) , e20220627
Resultados Imediatos após Múltiplos Enxertos Arteriais em Cirurgia de Revascularização Miocárdica no Estado de São Paulo: Estudo de Coorte
Resumo Fundamento Os resultados a curto prazo após o uso de enxertos arteriais ainda suscitam questionamentos e dúvidas na sociedade médica. Objetivo Comparar os resultados imediatos de pacientes submetidos à cirurgia de revascularização do miocárdio com enxerto arterial único versus enxertos arteriais múltiplos. Métodos Estudo de coorte transversal no Registro Paulista de Cirurgia Cardiovascular II (REPLICCAR II). Os dados perioperatórios de 3122 pacientes foram agrupados pelo número de enxertos arteriais utilizados e seus desfechos foram comparados: reoperação, infecção profunda da [...] Resumo Fundamento Os resultados a curto prazo após o uso de enxertos arteriais ainda suscitam questionamentos e dúvidas na sociedade médica. Objetivo Comparar os resultados imediatos de pacientes submetidos à cirurgia de revascularização do miocárdio com enxerto arterial único versus enxertos arteriais múltiplos. Métodos Estudo de coorte transversal no Registro Paulista de Cirurgia Cardiovascular II (REPLICCAR II). Os dados perioperatórios de 3122 pacientes foram agrupados pelo número de enxertos arteriais utilizados e seus desfechos foram comparados: reoperação, infecção profunda da
- 1 March 2023
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 120 (3) , e20220627
Open AccessResultados Imediatos após Múltiplos Enxertos Arteriais em Cirurgia de Revascularização Miocárdica no Estado de São Paulo: Estudo de Coorte
Resumo Fundamento Os resultados a curto prazo após o uso de enxertos arteriais ainda suscitam questionamentos e dúvidas na sociedade médica. Objetivo Comparar os resultados imediatos de pacientes submetidos à cirurgia de revascularização do miocárdio com enxerto arterial único versus enxertos arteriais múltiplos. Métodos Estudo de coorte transversal no Registro Paulista de Cirurgia Cardiovascular II (REPLICCAR II). Os dados perioperatórios de 3122 pacientes foram agrupados pelo número de enxertos arteriais utilizados e seus desfechos foram comparados: reoperação, infecção profunda da [...] Resumo Fundamento Os resultados a curto prazo após o uso de enxertos arteriais ainda suscitam questionamentos e dúvidas na sociedade médica. Objetivo Comparar os resultados imediatos de pacientes submetidos à cirurgia de revascularização do miocárdio com enxerto arterial único versus enxertos arteriais múltiplos. Métodos Estudo de coorte transversal no Registro Paulista de Cirurgia Cardiovascular II (REPLICCAR II). Os dados perioperatórios de 3122 pacientes foram agrupados pelo número de enxertos arteriais utilizados e seus desfechos foram comparados: reoperação, infecção profunda da
- 1 October 2022
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 106, 106931
Quality improvement program in Latin America decreases mortality after cardiac surgery: a before-after intervention study
The current challenge of cardiac surgery (CS) is to improve outcomes in adverse scenarios. The aim of this study was to assess the impact of a quality improvement program (QIP) on hospital mortality in the largest CS center in Latin America. Patients were divided into two groups: before (Jan 2013-Dec 2015, n = 3534) and after establishment of the QIP (Jan 2017-Dec 2019, n = 3544). The QIP consisted of the implementation of 10 central initiatives during 2016. The procedures evaluated were isolated coronary artery bypass grafting surgery (CABG), mitral valve surgery, aortic valve surgery, combined mitral and aortic valve surgery, and CABG associated with heart valve surgery. Propensity Score Matching (PSM) was used to adjust for inequality in patients' preoperative characteristics before and after the implementation of QIP. A multivariate logistic regression model was built to predict hospital mortality and validated using discrimination and calibration metrics. The PMS paired two groups using 5 variables, obtaining 858 patients operated before (non-QIP) and 858 patients operated after the implementation of the QIP. When comparing the QIP versus Non-QIP group, there was a shorter length of stay in all phases of hospitalization. In addition, the patients evolved with less anemia (P = 0.001), use of intra-aortic balloon pump (P = 0.003), atrial fibrillation (P = 0.001), acute kidney injury (P < 0.001), cardiogenic shock (P = 0.011), sepsis (P = 0.046), and hospital mortality (P = 0.001). In the multiple model, among the predictors of hospital mortality, the lack of QIP increased the chances of mortality by 2.09 times. The implementation of a first CS QIP in Latin America was associated with a reduction in length of hospital stay, complications and mortality after the cardiac surgeries analyzed.
- 1 October 2022
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 106, 106931
Quality improvement program in Latin America decreases mortality after cardiac surgery: a before-after intervention study
The current challenge of cardiac surgery (CS) is to improve outcomes in adverse scenarios. The aim of this study was to assess the impact of a quality improvement program (QIP) on hospital mortality in the largest CS center in Latin America. Patients were divided into two groups: before (Jan 2013-Dec 2015, n = 3534) and after establishment of the QIP (Jan 2017-Dec 2019, n = 3544). The QIP consisted of the implementation of 10 central initiatives during 2016. The procedures evaluated were isolated coronary artery bypass grafting surgery (CABG), mitral valve surgery, aortic valve surgery, combined mitral and aortic valve surgery, and CABG associated with heart valve surgery. Propensity Score Matching (PSM) was used to adjust for inequality in patients' preoperative characteristics before and after the implementation of QIP. A multivariate logistic regression model was built to predict hospital mortality and validated using discrimination and calibration metrics. The PMS paired two groups using 5 variables, obtaining 858 patients operated before (non-QIP) and 858 patients operated after the implementation of the QIP. When comparing the QIP versus Non-QIP group, there was a shorter length of stay in all phases of hospitalization. In addition, the patients evolved with less anemia (P = 0.001), use of intra-aortic balloon pump (P = 0.003), atrial fibrillation (P = 0.001), acute kidney injury (P < 0.001), cardiogenic shock (P = 0.011), sepsis (P = 0.046), and hospital mortality (P = 0.001). In the multiple model, among the predictors of hospital mortality, the lack of QIP increased the chances of mortality by 2.09 times. The implementation of a first CS QIP in Latin America was associated with a reduction in length of hospital stay, complications and mortality after the cardiac surgeries analyzed.
- 18 September 2022
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (11) , 3492-3506
Transit‐time flow measurement parameters after protamine infusion in CABG surgeries
Objective The objective of this study is to evaluate protamine sulfate effects on graft's blood flow by comparing transit-time flow measurement (TTFM) values before and after protamine administration. Methods This is an observational study with data collected between years 2018 and 2020. Immediate graft patency was evaluated using TTFM. Only patients with TTFM parameters registered before and after protamine infusion were included. The main three parameters studied were: mean graft flow (MGF), pulsatility index (PI), and diastolic flow (DF). In the first analysis, all conduits were evaluated regardless of the surgical technique used. In a second analysis, on-pump and off-pump groups were compared. Evaluated grafts were left internal thoracic artery, saphenous vein graft (SVG), radial artery, and right internal thoracic artery. Since SVG was numerically the most used graft, an exclusive analysis was created. Results Our study included 575 patients, resulting in a total of 1686 grafts, mean 2.93 grafts/patient. Off-pump surgery was performed in 158 patients. Before protamine infusion, inadequate TTFM parameters were observed in 3.8% of grafts. Overall, after protamine administration, MGF decreased in all grafts, but its reduction was not statistically significant. PI values increased in the SVG and DF values reduced in LIMA grafts. SVG group analysis showed that after protamine PI values were higher in OM1 and RCA. DF values increased in RCA. The comparison between off and on-pump surgeries, showed that in off-pump cases TTFM measures did not present statistically significant differences. Conclusion Significant variations were observed in TTFM values before and after protamine administration. Although different, those values remained within the normal reference ranges. We recommend that flow measurement should be performed before protamine infusion.
- 18 September 2022
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 37 (11) , 3492-3506
Transit‐time flow measurement parameters after protamine infusion in CABG surgeries
Objective The objective of this study is to evaluate protamine sulfate effects on graft's blood flow by comparing transit-time flow measurement (TTFM) values before and after protamine administration. Methods This is an observational study with data collected between years 2018 and 2020. Immediate graft patency was evaluated using TTFM. Only patients with TTFM parameters registered before and after protamine infusion were included. The main three parameters studied were: mean graft flow (MGF), pulsatility index (PI), and diastolic flow (DF). In the first analysis, all conduits were evaluated regardless of the surgical technique used. In a second analysis, on-pump and off-pump groups were compared. Evaluated grafts were left internal thoracic artery, saphenous vein graft (SVG), radial artery, and right internal thoracic artery. Since SVG was numerically the most used graft, an exclusive analysis was created. Results Our study included 575 patients, resulting in a total of 1686 grafts, mean 2.93 grafts/patient. Off-pump surgery was performed in 158 patients. Before protamine infusion, inadequate TTFM parameters were observed in 3.8% of grafts. Overall, after protamine administration, MGF decreased in all grafts, but its reduction was not statistically significant. PI values increased in the SVG and DF values reduced in LIMA grafts. SVG group analysis showed that after protamine PI values were higher in OM1 and RCA. DF values increased in RCA. The comparison between off and on-pump surgeries, showed that in off-pump cases TTFM measures did not present statistically significant differences. Conclusion Significant variations were observed in TTFM values before and after protamine administration. Although different, those values remained within the normal reference ranges. We recommend that flow measurement should be performed before protamine infusion.
- 5 April 2022
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 37 (7) , 1967-1968
A benchmark in the isolated tricuspid valve surgery is necessary
Advances in surgical techniques, enabling correction of regurgitation, and preserving the tricuspid valve, are also factors that encourage early surgical indication and improve long-term outcomes.
- 5 April 2022
- Published by Hindawi Limited in Journal of Cardiac Surgery
- Vol. 37 (7) , 1967-1968
A benchmark in the isolated tricuspid valve surgery is necessary
Advances in surgical techniques, enabling correction of regurgitation, and preserving the tricuspid valve, are also factors that encourage early surgical indication and improve long-term outcomes.